Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03223168 · ClinicalTrials.gov registry record · NA
Noninvasive Negative Pressure Ventilation to Support Failing Fontan Physiology
A NA study of Pediatric Congenital Heart Disease and Failing Fontan Physiology, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03223168 is a NA study of Pediatric Congenital Heart Disease and Failing Fontan Physiology that has completed, run by University of Michigan. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03223168, a NA study of Pediatric Congenital Heart Disease and Failing Fontan Physiology, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess for acute hemodynamic changes after implementation of noninvasive negative pressure ventilation (as compared with spontaneous respiration) in pediatric patients with Fontan failure using modern negative pressure ventilators
Conditions Studied
Interventions
- DEVICE Hayek RTX ventilator
Study Locations (1)
Michigan
- University of MIchigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-07-19 |
| Est. Completion | 2018-07-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03223168
The ClinicalTrials.gov registry entry for NCT03223168 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pediatric Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Hayek RTX ventilator is the first listed.
NCT03223168 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT03223168 about?
NCT03223168 is a clinical study titled "Noninvasive Negative Pressure Ventilation to Support Failing Fontan Physiology". The purpose of this study is to assess for acute hemodynamic changes after implementation of noninvasive negative pressure ventilation (as compared with spontaneous respiration) in pediatric patients with Fontan failure using modern negative pressure ventilators
What is the current status of trial NCT03223168?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-07-19. Estimated completion is 2018-07-19.
What conditions does trial NCT03223168 study?
This clinical trial studies the following conditions: Pediatric Congenital Heart Disease, Failing Fontan Physiology.
What interventions are being tested in trial NCT03223168?
The interventions under investigation include: Hayek RTX ventilator (DEVICE).
Who is sponsoring clinical trial NCT03223168?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03223168 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.